Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Severe diabetes associated with protease inhibitor therapy.

Visnegarwala F, Krause KL, Musher DM.

Ann Intern Med. 1997 Nov 15;127(10):947. No abstract available.

PMID:
9382374
2.

New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

Lee EC, Walmsley S, Fantus IG.

CMAJ. 1999 Jul 27;161(2):161-4. Review. No abstract available.

3.

[Clinical application of HIV protease inhibitors].

Chiba N, Shintani M, Ueno T, Hayashi H.

Tanpakushitsu Kakusan Koso. 1998 May;43(6):744-51. Review. Japanese. No abstract available.

PMID:
9612068
4.

Nelfinavir mesylate.

Tebas P, Powderly WG.

Expert Opin Pharmacother. 2000 Dec;1(7):1429-40. Review.

PMID:
11249476
5.

Nelfinavir: a review of its use in the management of HIV infection.

Perry CM, Frampton JE, McCormack PL, Siddiqui MA, Cvetković RS.

Drugs. 2005;65(15):2209-44. Review.

PMID:
16225378
6.

Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients.

Chronister CL, Gurwood AS.

J Am Optom Assoc. 1998 Nov;69(11):695-8. Review. No abstract available.

PMID:
9844321
7.

[Metabolic complications associated with use of protease inhibitors].

Mosnier-Pudar H.

Ann Med Interne (Paris). 2000 Jun;151(4):278-82. Review. French.

PMID:
10922955
8.

Management of protease inhibitor-associated hyperlipidemia.

Penzak SR, Chuck SK.

Am J Cardiovasc Drugs. 2002;2(2):91-106. Review.

PMID:
14727985

Supplemental Content

Support Center